Salih Levent Cinar

Salih Levent Cinar

Auto-generated profile, based on publicly available information

Salih Levent Cinar

Department of Dermatology Erciyes University Faculty of Medicine Kayseri Turkey

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
GAGokhan Acmaz
Gokhan Acmaz
LCL. Cınar
L. Cınar
BAB. Acmaz
B. Acmaz
HAH. Aksoy
H. Aksoy
YKYusuf Taner Kafadar
Yusuf Taner Kafadar
IMI. Muderris
I. Muderris
Introduction. Many patients who were diagnosed as polycystic ovary syndrome- (PCOS-) related acne were not capable of sustaining or beginning oral contraceptive pills (OCPs) due to pill scaring, contraindications of OCP use, migraine, or smoking. In this situation, oral isotretinoin treatment may become an important option for PCOS-related acne. The aim of the study was to determine the effects of isotretinoin treatment on PCOS patients who were complicated with severe cystic acne. Materials and Methods. This study consisted of 40 female patients diagnosed as PCOS complicated with severe cystic acne. These patients were not eligible candidates for OCP use due to migraine, thrombophilia, heavy smoking, or pill scare. To establish baseline values of hormone levels, on days 2–5 of the menstrual cycle, venous blood samples were obtained. Moreover Modified Ferriman-Gallwey (mFG) score, acne score (AS), follicle count, and bilateral ovarian volumes were evaluated both before and after isotretinoin treatment. Results. Isotretinoin treatment significantly decreased Ferriman-Gallwey score, free testosterone, insulin level, hemoglobin level, acne score, and ovarian volume. Increased triglyceride and cholesterol levels were detected after treatment. Conclusion. Isotretinoin treatment may have beneficial effects on free testosterone, insulin, acne score, and Ferriman-Gallwey score. Solely isotretinoin administration may supply adequate healing in PCOS patients’ symptoms complicated with severe cystic acne who is not eligible candidates for OCP use. This trial is registered with Clinicaltrials.gov NCT02855138.

7 June 2013 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
MCMehmet Canpolat
Mehmet Canpolat
HPHuseyin Per
Huseyin Per
HGHakan Gumus
Hakan Gumus
AYAli Yikilmaz
Ali Yikilmaz
EUEkrem Unal
Ekrem Unal
SKSefer Kumandas
Sefer Kumandas

11 December 2015 in Cutaneous and Ocular Toxicology
Verified
Journal Article
Closed access
PDF file
LÇLevent Çinar
Levent Çinar
DKDemet Kartal
Demet Kartal
CECan Ergin
Can Ergin
HAHuseyin Aksoy
Huseyin Aksoy
MKMert Ali Karadag
Mert Ali Karadag
MBMurat Borlu
Murat Borlu
Systemic isotretinoin has a positive effect on male fertility. Since the hormone levels did not change significantly, this positive effect of isotretinoin is not via the hypothalamic-pituitary-gonadal axis but can be due to its regenerative and proliferative effects on the testes.

30 January 2015 in Gynecologic and Obstetric Investigation
Verified
Journal Article
Closed access
PDF file
HAHüseyin Aksoy
Hüseyin Aksoy
LCLevent Cinar
Levent Cinar
GAGokhan Acmaz
Gokhan Acmaz
UAUlku Aksoy
Ulku Aksoy
TATurgut Aydin
Turgut Aydin
DKDemet Kartal
Demet Kartal
Backgroud/Aims: Widely prescribed in routine practice, isotretinoin has an unknown impact on ovarian reserve. With a long history in acne treatment and numerous potential side effects, it is surprising that very few prospective studies have investigated its effect on ovarian reserve. Therefore, we aimed to evaluate the impact of oral isotretinoin on ovarian reserve based on hormonal parameters, anti-Müllerian hormone (AMH), ovarian volume (OV), and antral follicle count (AFC) in women of reproductive age with acne. Methods: Our study group consisted of 82 women of reproductive age with acne who were treated with oral isotretinoin. The patients were evaluated for ovarian reserve prior to therapy and reevaluated 6 months after isotretinoin treatment with regard to hormonal parameters, AMH, OV, and AFC. Results: Significant differences were found between the pre- and posttreatment period for AMH [2.20 ng/ml (25th-75th percentile 1.14-4.07) vs. 1.31 ng/ml (0.32-2.28)], total AFC [16 (14-18.25) vs. 12.5 (10-15)], and total OV [23 ml (18-29) vs. 15 ml (13-18); p < 0.001]. Conclusion: Our study is the first to analyze the levels of serum AMH, AFC, and OV together in patients treated with oral isotretinoin for acne. The results of our study demonstrated that oral isotretinoin had a significant negative effect on ovarian reserve.

1 January 2016 in Advances in Dermatology and Allergology
Verified
Journal Article
Open access
DKDemet Kartal
Demet Kartal
MBMurat Borlu
Murat Borlu
SÇSalih Levent Çınar
Salih Levent Çınar
AKAyten Kesikoğlu
Ayten Kesikoğlu
SUSerap Utaş
Serap Utaş
Introduction : The association between vitiligo and thyroid disease is not fully investigated especially in paediatric patients. Aim : To determine the incidence of vitiligo and thyroid disorders in children. This is the first report from middle Anatolia and the second report from Turkey....

5 July 2016 in Cutaneous and Ocular Toxicology
Verified
Journal Article
Closed access
PDF file
SCSalih Levent Cinar
Salih Levent Cinar
DKDemet Kartal
Demet Kartal
HAHüseyin Aksoy
Hüseyin Aksoy
ECElif Cinar
Elif Cinar
TATurgut Aydin
Turgut Aydin
MBMurat Borlu
Murat Borlu
Background/Objective: Acne vulgaris is one of the most common diseases of the youth. Systemic isotretinoin is the only drug which acts on all of the etiopathogenic mechanisms of acne. Isotretinoin has some well known side effects. Besides these, there is a suspicion whether it affects fertility or not. Previously, we conducted a study about isotretinoin’s effect on ovarian reserve which showed deteriorative reserve. In this study we aimed to evaluate the long term effects of systemic isotretinoin on female fertility. Materials and Methods: Of the 82 female patients who were enrolled in the first study, 79 patients were included in this study. Twelve months after the end of systemic isotretinoin treatment, patients were re-evaluated by using the same parameters which include anti-Mullerian hormone (AMH), ovarian volume (OV), antral follicle count (AFC), follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, free testosterone and total testosterone. Results: The changes in the mean AMH, OV and AFC were statistically significant between the sixth and eighteenth months (the end of systemic isotretinoin treatment and twelve months treatment free). The mean AMH, OV and AFC values at the beginning and at the eighteenth month were statistically similar. Conclusion: The deteriorative effects of systemic isotretinoin treatment on ovarian reserve, which can be accepted as an indicator of female fertility, diminish in time.